Science Advances · 14 August 2026 · From issue 23
Mito-TEMPO improves survival rates in npc1 -knockout zebrafish by reducing oxidative stress and enhancing mitophagy via Sod2
In zebrafish, a mitochondria-protecting drug raised survival and eased liver damage from a rare genetic disease.
Wenhao Zhao, Xudong Hu et al.
A rare disease called Niemann-Pick type C harms the liver and brain in young patients. Few treatments exist to help them live longer. In zebrafish bred to lack a key gene tied to this disease, a drug called Mito-TEMPO helped fish survive longer. The drug protects tiny cell power stations from damage. It worked by boosting a protective protein and helping cells clear out damaged parts.
Integrity screen: passed (3 checks) Checked 19 August 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue